HER2 Support Group Forums - View Single Post - Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer

News · 07-20-2012, 09:33 PM

The U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer.

More...

07-20-2012, 09:33 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,133	Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer The U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. More...